APEX1 and non-small cell lung carcinoma: We found that APEX1 was upregulated in 517 NSCLC samples compared to 59 normal tissue samples, with a statistically significant difference between the two groups (p < 0.01, Fig. 1a and Additional file 2: Table S2).